Ling Lin, MD, MS

    Calculated based on number of publications stored in Pure and citations from Scopus

    Research activity per year

    Personal profile

    Research interests

    Dr. Lin is interested in the pathogenesis and therapeutics of tissue fibrosis and inflammation. She has defined several molecular mechanisms of tPA and LRP-1 signaling in regulating fibroblast activation and survival during renal fibrogenesis. Her work has also uncovered a novel regulatory mechanism of NF-κB activation involving annexin A2-mediated CD11b integrin signal pathway, as well as the previously unrecognized role of NF-κB in macrophage migration and polarity shift from M2 to M1 during renal inflammation.

    Currently, Dr. Lin is utilizing innovative approaches to investigate the role and signaling mechanism of cell-cell communication, as well as oxidative stress, in the pathogenesis of tissue fibrosis and inflammation, and to develop specific treatment targeting fibrosis and inflammation.

    Teaching and educational interests

    Dr. Lin is involved in the research advising and mentoring of graduate students, postdocs and visiting scholars.

    Expertise related to UN Sustainable Development Goals

    In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

    • SDG 3 - Good Health and Well-being

    Education/Academic qualification

    MS, Nanjing University Medical School

    … → 1999

    MD, Nanjing University Medical School

    … → 1997

    External positions

    Member, American Society of Nephrology

    2008 → …


    Dive into the research topics where Ling Lin is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
    • 1 Similar Profiles

    Collaborations and top research areas from the last five years

    Recent external collaboration on country/territory level. Dive into details by clicking on the dots or